Abstract:Background: The placenta exerts a crucial role in fetus growth and development during gestation, protecting the fetus from maternal drugs and chemical exposure. However, diverse drugs and chemicals (xenobiotics) can penetrate the maternal placental barrier, leading to deleterious, adverse effects concerning fetus health. Moreover, placental enzymes can metabolize drugs and chemicals into more toxic compounds for the fetus. Thus, evaluating the molecular mechanisms through which drugs and chemicals transfer and undergo metabolism across the placental barrier is of vital importance. In this aspect, this comprehensive literature review aims to provide a holistic approach by critically summarizing and scrutinizing the potential molecular processes and mechanisms governing drugs and chemical transfer and metabolism across the placental barrier, which may lead to fetotoxicity effects, as well as analyzing the currently available experimental methodologies used to assess xenobiotics placental transfer and metabolism. Methods: A comprehensive and in-depth literature review was conducted in the most accurate scientific databases such as PubMed, Scopus, and Web of Science by using relevant and effective keywords related to xenobiotic placental transfer and metabolism, retrieving 8830 published articles until 5 February 2024. After applying several strict exclusion and inclusion criteria, a final number of 148 relevant published articles were included. Results: During pregnancy, several drugs and chemicals can be transferred from the mother to the fetus across the placental barrier by either passive diffusion or through placental transporters, resulting in fetus exposure and potential fetotoxicity effects. Some drugs and chemicals also appear to be metabolized across the placental barrier, leading to more toxic products for both the mother and the fetus. At present, there is increasing research development of diverse experimental methodologies to determine the potential molecular processes and mechanisms of drug and chemical placental transfer and metabolism. All the currently available methodologies have specific strengths and limitations, highlighting the strong demand to utilize an efficient combination of them to obtain reliable evidence concerning drug and chemical transfer and metabolism across the placental barrier. To derive the most consistent and safe evidence, in vitro studies, ex vivo perfusion methods, and in vivo animal and human studies can be applied together with the final aim to minimize potential fetotoxicity effects. Conclusions: Research is being increasingly carried out to obtain an accurate and safe evaluation of drug and chemical transport and metabolism across the placental barrier, applying a combination of advanced techniques to avoid potential fetotoxic effects. The improvement of the currently available techniques and the development of novel experimental protocols and methodologies are of major importance to protect both the mother and the fetus from xenobiotic exposure, as well as to minimize potential fetotoxicity effects.

Bidirectional Transfer Study of Polystyrene Nanoparticles across the Placental Barrier in an ex Vivo Human Placental Perfusion Model

Size-dependent Placental Retention Effect of Liposomes in ICR Pregnant Mice: Potential Superiority in Placenta-Derived Disease Therapy

Advance in Placenta Drug Delivery: Concern for Placenta-Originated Disease Therapy.

Translocation of (ultra)fine particles and nanoparticles across the placenta; a systematic review on the evidence of in vitro, ex vivo, and in vivo studies

Nanoparticles Dysregulate the Human Placental Secretome with Consequences on Angiogenesis and Vascularization

A 3D Human Placenta-on-a-chip Model to Probe Nanoparticle Exposure at the Placental Barrier

Single pulmonary nanopolystyrene exposure in late-stage pregnancy dysregulates maternal and fetal cardiovascular function

Mechanistic toxicity assessment of differently sized and charged polystyrene nanoparticles based on human placental cells

Transplacental Transport of Per- and Polyfluoroalkyl Substances (PFAS): Mechanism Exploration Via BeWo Cell Monolayer Model

Flow cytometric analysis of the murine placenta to evaluate nanoparticle platforms during pregnancy

Mechanisms of Transplacental Transport and Barrier of Polybrominated Diphenyl Ethers: A Comprehensive Human, Sprague-Dawley Rat, BeWo Cell and Molecular Docking Study

Effects of Gestational Age and Surface Modification on Materno-Fetal Transfer of Nanoparticles in Murine Pregnancy

Placental transfer and hazards of silver nanoparticles exposure during pregnancy: a review

Fetus Exposure to Drugs and Chemicals: A Holistic Overview on the Assessment of Their Transport and Metabolism across the Human Placental Barrier

Modelling the maternal‐fetal interface: An in vitro approach to investigate nutrient and drug transport across the human placenta

Novel electrospun chitosan/PEO membranes for more predictive nanoparticle transport studies at biological barriers

Formulation effects on paclitaxel transfer and uptake in the human placenta

Multi-endpoint toxicological assessment of polystyrene nano- and microparticles in different biological models in vitro

The Potential Toxicity of Polystyrene Nanoplastics to Human Trophoblasts in Vitro.

Nanotechnological approaches for the treatment of placental dysfunction: recent trends and future perspectives

Intrauterine Inflammation Increases Materno-Fetal Transfer of Gold Nanoparticles in A Size-Dependent Manner in Murine Pregnancy